Stay updated with breaking news from Multidisciplinary Head. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Genmab A/S (GMAB) Q1 2022 Earning Conference Call May 11, 2022 12:00 PM ET Company Participants Jan van de Winkel - President and Chief Executive Officer Anthony Pagano - Chief Financial...
28.04.2022 - Seagen Inc. (Nasdaq:SGEN) reported financial results today for the first quarter ended March 31, 2022. The Company also highlighted PADCEV (enfortumab vedotin-ejfv), TUKYSA (tucatinib), ADCETRIS (brentuximab vedotin) and TIVDAK (tisotumab ...
High response rate with oncolytic virus plus immunotherapy in cutaneous lesions
High precision for T stage, extracapsular extension, BRAF mutation
High precision for T stage, extracapsular extension, BRAF mutation